Related Experiment Video
Updated: May 22, 2026

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
Published on: May 10, 2017
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
Eleftherios Sachlos1, Ruth M Risueño, Sarah Laronde
1McMaster Stem Cell and Cancer Research Institute, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Abstract:
Selective targeting of cancer stem cells (CSCs) offers promise for a new generation of therapeutics. However, assays for both human CSCs and normal stem cells that are amenable to robust biological screens are limited. Using a discovery platform that reveals differences between neoplastic and normal human pluripotent stem cells (hPSC), we identify small molecules from libraries of known compounds that induce differentiation to overcome neoplastic self-renewal. Surprisingly, thioridazine, an antipsychotic drug, selectively targets the neoplastic cells, and impairs human somatic CSCs capable of in vivo leukemic disease initiation while having no effect on normal blood SCs. The drug antagonizes dopamine receptors that are expressed on CSCs and on breast cancer cells as well. These results suggest that dopamine receptors may serve as a biomarker for diverse malignancies, demonstrate the utility of using neoplastic hPSCs for identifying CSC-targeting drugs, and provide support for the use of differentiation as a therapeutic strategy.
Insights
Thioridazine, an antipsychotic, selectively targets cancer stem cells (CSCs) by antagonizing dopamine receptors. This discovery supports using differentiation as a therapeutic strategy and highlights dopamine receptors as potential cancer biomarkers.
Area of Science:
- Oncology
- Stem Cell Biology
- Pharmacology
Background:
- Selective targeting of cancer stem cells (CSCs) is crucial for novel therapeutics.
- Existing assays for human CSCs and normal stem cells are limited for biological screening.
Purpose of the Study:
- To identify small molecules that selectively target and induce differentiation in neoplastic cells.
- To explore the potential of targeting dopamine receptors on CSCs.
Main Methods:
- Utilized a discovery platform comparing neoplastic and normal human pluripotent stem cells (hPSCs).
- Screened libraries of known compounds to identify molecules inducing differentiation.
- Investigated the effect of thioridazine on CSCs and normal stem cells in vitro and in vivo.
Main Results:
- Thioridazine selectively targets neoplastic cells and impairs human somatic CSCs.
- Normal blood stem cells were unaffected by thioridazine.
- Dopamine receptors, expressed on CSCs and breast cancer cells, are antagonized by thioridazine.
Conclusions:
- Neoplastic hPSCs are valuable for identifying CSC-targeting drugs.
- Differentiation is a viable therapeutic strategy for overcoming neoplastic self-renewal.
- Dopamine receptors may serve as biomarkers for various malignancies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs that Destabilize Microtubules

